Hebei Changshan Biochemical Pharmaceutical is an API manufacturer based in China. It holds 2 active US drug master files and one valid CEP across a filed portfolio of 2 molecules. Its filings concentrate with RCETH (BY) and UZPHARM (UZ). Its GMP standing is certified by UZPHARM (UZ), EMA and US FDA. Its most recent recorded inspection, by US FDA, closed on 5 April 2024 as NAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Shijiazhuang, China | Not on file |
| China, China | 3010849972 |
| Molecule | Regulators | Docs |
|---|---|---|
| Heparin Sodium | EDQM, US FDA | 2 |
| Enoxaparin | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| RCETH (BY) | 1 | None |
| UZPHARM (UZ) | 1 | 1 |
| EMA | None | 1 |
| US FDA | None | 1 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Hebei Changshan Biochemical Pharmaceutical comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.